// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Carbon dioxide (CO2) insufflation: a potential source of error in TLCO measurement

Ben Knox-Brown - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The effect of time elapsed since expectoration on sputum eosinophil differential cell counts

Gael Tavernier - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Macrophage inflammatory responses to Non-typeable Haemophilus influenzae (NTHi) are strain-dependent

Jodie Ackland - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

IFN-lambda

Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies

Cosma Mirella Spalluto - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Influenza

Interferon

Exosomal miRNAs and association with pulmonary tuberculosis

Esmaeil Mortaz - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

The Significance of IgG to Aspergillus in Non-Cystic Fibrosis Bronchiectasis

Christopher Huntley - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Derivation und Validation of a Primary Ciliary Dyskinesia Computed Tomography (PCD-CT) Score in patients with bronchiectasis

Jessica Rademacher - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients

Martina Oriano - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Elaszym

Chest radiographs following admission with community acquired pneumonia: a retrospective audit

Sara Upperton - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Persistent bacterial bronchitis in adults – a precursor to Bronchiectasis?

Simon Finch - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Clinical efficacy and safety evaluation of a novel seawater-based hypertonic solution in common cold patients

Sreedar Anapurapu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Outcomes of intrapleural tissue plasminogen activator (tPA) and deoxyribnuclease (DNase) for IPC-related pleural infection

Deirdre Fitzgerald - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Pleural empyema accuracy on Hospital Episode Statistics (HES): a validation study

Fergus Hamilton - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

IPC-related pleural infection vs. colonisation - to treat or not to treat?

Katie Ferguson - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of Procalcitonin in management of pleural infections

Syed Mohannad - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Serum Procalcitonin for diagnosing and monitoring response in pleural infection

Syed Mohammed - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC)

Felix C. Ringshausen - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The relationship between radiological severity and clinical phenotype in bronchiectasis

Hani Abo-Leyah - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

A broad immunological screening may impact treatment in bronchiectasis patients

Elisa Franceschi - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

LSC - 2019 - Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response

Holly Rachael Keir - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved